Taking place in Prague, the largest city of the Czech Republic, the FMF World Congress will bring together leading experts and researchers from all around the world to present and discuss the latest developments in fetal medicine.
Key topics at this year's congress include: Spina bifida, Fetal and Maternal Cardiology, Maternal-fetal Medicine, Pre-term Birth, and Preeclampsia, among others. See the final program here.
Roche has a long-standing commitment to women's health diagnostics, delivering innovations that disrupt the standard of care to improve health management.
This includes products like the Harmony(R) prenatal test.
cfDNA-based non-invasive prenatal testing (NIPT) has been recognized as the most sensitive and specific screening option for trisomy 21, trisomy 18, and trisomy 131. It also has the added benefit of being available during the first trimester of pregnancy.
References:
